HomeANTX • NASDAQ
add
AN2 Therapeutics Inc
Previous close
$1.08
Day range
$1.05 - $1.08
Year range
$0.87 - $22.15
Market cap
31.33M USD
Avg Volume
1.10M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 15.88M | -4.34% |
Net income | -14.44M | 8.66% |
Net profit margin | — | — |
Earnings per share | -0.48 | 40.74% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 104.54M | 9.74% |
Total assets | 108.48M | 9.66% |
Total liabilities | 10.13M | -9.27% |
Total equity | 98.35M | — |
Shares outstanding | 29.84M | — |
Price to book | 0.33 | — |
Return on assets | -34.56% | — |
Return on capital | -38.00% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -14.44M | 8.66% |
Cash from operations | -14.38M | -12.16% |
Cash from investing | 16.46M | 108.96% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | 2.08M | -85.28% |
Free cash flow | -8.98M | -29.03% |
About
Founded
2017
Headquarters
Website
Employees
41